Your browser version may not work well with NCBI's Web applications. More information here...
1: J Clin Virol. 2006 Jun;36(2):156-8. Epub 2006 Apr 4.Click here to read Links

Yellow fever vaccine-associated viscerotropic disease and death in Spain.

Doblas A, Domingo C, Bae HG, Bohórquez CL, de Ory F, Niedrig M, Mora D, Carrasco FJ, Tenorio A.

Emergency and Critical Care Department, Juan Ramón Jiménez Hospital, Huelva, Spain.

Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) is a recently described severe adverse event after yellow fever vaccination, and some cases have been reported in different countries [Anonymous. Effects of yellow fever and vaccination. Lancet 2001;358(9296):1907-9]. Herein we describe a YEL-AVD case in a young woman, who died after vaccination with 17D-204 strain. Clinical, serological and immunochemical analysis as well as virus detection, quantification, sequence analysis and cytokine release, were performed. Further investigations on yellow fever vaccine adverse events, and carefully analysis of the immune response elicited are important tasks for the future.

PMID: 16597510 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Yellow Fever Vaccine (YF-VAX® )

    Yellow fever is a serious disease caused by the yellow fever virus. It is spread through the bite of an infected mosquito andcannot be spread directly from person to person. It is found in certain parts of Africa and Sou...

  • Source: AHFS Consumer Medication Information